Literature DB >> 16001348

Lansoprazole-associated collagenous colitis: a case report.

M Rammer1, A Kirchgatterer, W Höbling, P Knoflach.   

Abstract

A 57-year-old man developed chronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease. Four weeks later the patient was admitted to our hospital. By repeated testing other causes of diarrhea, e. g., infectious diarrhea including Clostridium difficile colitis were excluded. Endoscopy showed a normal colon, histopathology of random biopsies of all sections of the colon demonstrated the characteristic features of collagenous colitis. Withdrawal of lansoprazole lead to prompt and sustained relief. Two months later repeat colonoscopy with biopsies showed no evidence of collagenous colitis. Collagenous colitis as a subtype of microscopic colitis is a rare cause of chronic diarrhea with unknown pathogenesis. The reported case represents an unusual association between medication with the proton pump inhibitor lansoprazole and the development of collagenous colitis suggesting the importance of evaluation of drug use in patients with microscopic colitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16001348     DOI: 10.1055/s-2005-858155

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  5 in total

1.  Collagenous colitis appeared after 6-year administration of lansoprazole.

Authors:  Koji Sawada; Mikihiro Fujiya; Kentaro Itabashi; Yasuyuki Suzuki; Koji Kubo; Toshie Nata; Nobuhiro Ueno; Yuhei Inaba; Kentaro Moriichi; Kotaro Okamoto; Katsuya Ikuta; Hiroki Tanabe; Yusuke Mizukami; Yoshitake Takagi; Yutaka Kohgo
Journal:  Clin J Gastroenterol       Date:  2009-11-28

Review 2.  Clostridium difficile-associated disease: changing epidemiology and implications for management.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  A unique case of collagenous colitis presenting as protein-losing enteropathy successfully treated with prednisolone.

Authors:  Soichi Sano; Keiko Yamagami; Ayako Tanaka; Minako Nishio; Tomoyuki Nakamura; Yuki Kubo; Takeshi Inoue; Wataru Ueda; Kiyotaka Okawa; Katsunobu Yoshioka
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

4.  Lansoprazole-associated collagenous colitis: diffuse mucosal cloudiness mimicking ulcerative colitis.

Authors:  Mitsuro Chiba; Takeshi Sugawara; Haruhiko Tozawa; Hidehiko Tsuda; Toru Abe; Takuo Tokairin; Iwao Ono; Eriko Ushiyama
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

5.  European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations.

Authors:  Stephan Miehlke; Danila Guagnozzi; Yamile Zabana; Gian E Tontini; Anne-Marie Kanstrup Fiehn; Signe Wildt; Johan Bohr; Ole Bonderup; Gerd Bouma; Mauro D'Amato; Peter J Heiberg Engel; Fernando Fernandez-Banares; Gilles Macaigne; Henrik Hjortswang; Elisabeth Hultgren-Hörnquist; Anastasios Koulaouzidis; Jouzas Kupcinskas; Stefania Landolfi; Giovanni Latella; Alfredo Lucendo; Ivan Lyutakov; Ahmed Madisch; Fernando Magro; Wojciech Marlicz; Emese Mihaly; Lars K Munck; Ann-Elisabeth Ostvik; Árpád V Patai; Plamen Penchev; Karolina Skonieczna-Żydecka; Bas Verhaegh; Andreas Münch
Journal:  United European Gastroenterol J       Date:  2021-02-22       Impact factor: 4.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.